Position in ELAN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$193,295,842
+$39,724,429 QoQ
Shares Held
7,854,362
+22.4% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 515 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,439,546 across 76 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in ELAN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,295,842 | 7,854,362 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $153,571,413 | 6,417,527 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $142,401,768 | 9,972,113 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $49,291,912 | 4,694,468 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $76,943,947 | 4,726,287 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $89,966,073 | 6,037,992 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $46,632,564 | 4,148,805 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $38,841,625 | 3,860,997 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,776,715 | 3,593,268 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,730,000 | 3,414,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $37,955,621 | 3,058,471 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $69,857,509 | 2,461,505 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $75,827,815 | 2,377,793 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $126,647,425 | 4,300,422 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $36,102,544 | 1,177,129 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $57,910,590 | 2,073,419 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,167,354 | 846,963 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,302,899 | 549,482 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||